Aspectos clínicos, epidemiológicos y mortalidad de pacientes en uso de terapia antifúngica en un hospital universitario del Triângulo Mineiro, Brasil
DOI:
https://doi.org/10.17058/reci.v14i1.18687Resumen
Justificación y Objetivos: Las infecciones fúngicas invasivas presentan una alta morbilidad y mortalidad en los pacientes hospitalizados, incluidos aquellos que utilizan la terapia adecuada. El objetivo fue evaluar la terapia antimicótica profiláctica y preventiva, las características clínicas, epidemiológicas y la mortalidad de pacientes ingresados en una sala de enfermedades infecciosas de un hospital público de alta complejidad en Uberlândia, Minas Gerais, Brasil. Métodos:Este es un estudio retrospectivo realizado en la sala de enfermedades infecciosas de un hospital universitario público en Brasil. Los datos recogidos de las historias clínicas se referían a pacientes hospitalizados en 2019 y 2020 y que utilizaban antifúngicos azoles (fluconazol, itraconazol o voriconazol), equinocandinas (anidulafungina) y polienos (anfotericina B). Resultados: Durante el período, 111 pacientes usaron uno o más antifúngicos. El tiempo de estancia hospitalaria (29,35 días, p= 0,0252), promedio de días de uso de antibacteriano (23,5 días; p=0,0164), SIDA (p=0,0397), uso de ventilación mecánica (VM; p<0,001) y uso de sonda nasoenteral (p<0,01) fueron variables que se relacionaron con el desenlace de muerte. La infección por hongos se confirmó en cultivo en 79 (71,2%) pacientes que usaban medicamentos antimicóticos. Los agentes fúngicos más frecuentes fueron Candida spp. (36; 32,4%) y Cryptococcus spp. (22; 19,8%), mostrando relación entre la infección por estos hongos y la mortalidad (p<0,05; 7,61 y 5,53, respectivamente). En cuanto a la terapia, 56 (50,4%) pacientes estaban en terapia empírica; 33 (29,7%) la utilizaron como terapia diana; y 22 (19,8%) la utilizaron como terapia preventiva. Conclusión: La mortalidad fue más frecuente entre los pacientes con mayor tiempo de internación, que tenían SIDA y que utilizaron antibióticos, ventilación mecánica y sonda nasoenteral en algún momento de la internación. El tipo de terapia antifúngica no influyó en la mortalidad de estos pacientes.
Descargas
Citas
Bongomin F, Gago S, Oladele RO, et al. Global and multi-national prevalence of fungal diseases- estimate precision. J Fungi (Basel). 2017;3(4):57. https://doi.org/10.3390/jof3040057
Van Rhijn N, Bromley M. The consequences of our changing environment on life threatening and debilitating fungal diseases in humans. J Fungi (Basel). 2021;7(5):367. https://doi.org/10.3390/jof7050367
Pemán J, Zaragoza R, Salavert M. Control y prevención de las infecciones nosocomiales y asociadas a cuidados sanitários causadas por especies de Candida y otras levaduras. Rev Esp Chemioter. 2013;26(4):298–311. https://seq.es/seq/0214-3429/26/4/peman.pdf
Jenks JD, Cornely OA, Chen SC, et al. Breakthrough invasive fungal infections: Who is at risk? Mycoses. 2020;63(10):1021–32. https://doi.org/10.1111/myc.13148
Vitális E, Nagy F, Tóth Z, et al. Candida biofilm production is associated with higher mortality in patients with candidaemia. Mycoses. 2020;63(4):352–60. https://doi.org/10.1111/myc.13049
González-Lara MF, Torres-González P, Rangel-Cordero A, et al. Identification and susceptibility testing of Candida spp. directly from yeast-positive blood cultures with Vitek 2. Diagn Microbiol Infect Dis. 2017;89(3):202–4. https://doi.org/10.1016/j.diagmicrobio.2017.07.004
Neufeld PM. COVID-19 and the diagnosis of invasive pulmonary aspergillosis. Revista Brasileira de Análises Clínicas. 2020;52(2):173–5. https://doi.org/10.21877/2448-3877.20200019
Mourad A, Perfect JR. Present and future therapy of Cryptococcus infections. J Fungi (Basel). 2018;4(3):79. https://doi.org/10.3390/jof4030079
Aguiar PADF, Pedroso RDS, Borges AS, et al. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital. Rev Inst Med Trop Sao Paulo. 2017;59:e13. https://doi.org/10.1590/S1678-9946201759013
Damasceno-Escoura AH, Mora DJ, Cardeal AC, et al. Histoplasmosis in HIV-infected patients: Epidemiological, clinical and necropsy data from a Brazilian teaching hospital. Mycopathologia. 2020;185(2):339–46. https://doi.org/10.1007/s11046-020-00435-y
Gavronski, S, Botelho, TKR., Cordova, CMM. Laboratory diagnosis of invasive aspergillosis: evaluation of molecular methods and antigen detection. Revista Brasileira de Análises Clínicas. 2016; 48(2): 96–109. https://www.rbac.org.br/artigos/diagnostico-laboratorial-de-aspergilose-invasiva-avaliacao-de-metodos-moleculares-e-deteccao-de-antigenos-48-n-2/
Cornely OA, Lass-Flörl C, Lagrou K, et al. Improving outcome of fungal diseases - Guiding experts and patients towards excellence. Mycoses 2017;60(7):420–5. https://doi.org/10.1111/myc.12628
Nivoix Y, Launoy A, Lutun P, et al. Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. J Antimicrob Chemother. 2012;67(10):2506–13. https://doi.org/10.1093/jac/dks256
Brasil. Gerência Geral de Tecnologia et al. Nota técnica GVIMS/GGTES/ANVISA nº 04/2021: orientações para vigilância, identificação, prevenção e controle de infecções fúngicas invasivas em serviços de saúde no contexto da pandemia da COVID-19. 2021. https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/notas-tecnicas/notas-tecnicas-vigentes/nota-tecnica-04-2021-infeccoes-fungicas-e-covid19.pdf/view. Accessed on February 2nd, 2024.
Colombo AL, Guimaraes T; Camargo LFA, et al. Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Braz J Infect Dis. 2013;7(3):283–312. http://dx.doi.org/10.1016/j.bjid.2013.02.001
Souza MC, Santos AG, Reis AM. Drug utilization study of systemic antifungal agents in a Brazilian tertiary care hospital. Int J Clin Pharm. 2016;38(6):1398–406. https://doi.org/10.1007/s11096-016-0382-6
Koch E, Rada G. Is preemptive antifungal therapy a good alternative to empirical treatment in prolonged febrile neutropenia? Medwave. 2016; 16 Suppl 2: e6463. https://doi.org/10.5867/medwave.2016.6463
Portugal RD, Garnica M, Nucci M. Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve. J Clin Oncol. 2009;27(23): 3849–54. https://doi.org/10.1200/JCO.2008.21.0856
Sprute R, Nacov JA, Neofytos D, et al. Antifungal prophylaxis and pre-emptive therapy: When and how? Mol Aspect Med. 2023;92:101190. https://doi.org/10.1590/1982-0194201900094
Çağlar İ, Devrim I, Özdemir H, et al. Antifungal consumption, indications and selection of antifungal drugs in paediatric tertiary hospitals in Turkey: Results from the first national point prevalence survey. J Glob Antimicrob Resist. 2018;15:232–8. https://doi.org/10.1016/j.jgar.2018.08.007
Leadebal ODCP, Pereira RR, Nóbrega LMB, et al. Prevalence of high risk of clinical complications associated with death from AIDS. Acta Paul Enferm. 2019;32(6):683–90. https://doi.org/10.1590/1982-0194201900094
Panis C, Matsuo T, Reiche EM. Nosocomial infections in human immunodeficiency virus type 1 (HIV-1) infected and AIDS patients: major microorganisms and immunological profile. Braz J Microbiol. 2009;40(1):155–62. https://doi.org/10.1590/S1517-838220090001000027
Oliveira AB, Dias OM, Mello MM, et al. Factors associated with increased mortality and prolonged length of stay in an adult intensive care unit. Rev Bras Ter Intensiva. 2010;22(3):250–6. https://doi.org/10.1590/S0103-507X2010000300006
Zilberberg MD, Kramer AA, Higgins TL, et al. Prolonged acute mechanical ventilation: implications for hospital benchmarking. Chest. 2009;135(5):1157–62. https://doi.org/10.1378/chest.08-1928
Guay J, Ochroch EA, Kopp S. Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in adults without acute lung injury. Cochrane Database Syst Rev. 2018;7(7):CD011151. https://doi.org/10.1002/14651858.CD011151.pub3
World Health Organization. Conceptual framework for the international classification for patient safety. 2009. https://www.who.int/patientsafety/taxonomy/icps_full_report.pdf. Accessed on February 2nd, 2024.
Fan L, Liu Q, Gui L. Efficacy of nonswallow nasogastric tube intubation: a randomised controlled trial. J Clin Nurs. 2016;25(21–22):3326–32. https://doi.org/10.1111/jocn.13398
Motta APG, Rigobello MCG, Silveira RCCP, et al. Nasogastric/ nasoenteric tube-related adverse events: an integrative review. Rev Lat Am Enfermagem. 2021;29:e3400. https://doi.org/10.1590/1518-8345.3355.3400
Brooks M. Pneumothorax events linked to placement of enteral feeding tube. New York: Medscape; 2018.
Thaden JT, Maskarinec SA. When two for the price of one isn't a bargain: estimating prevalence and microbiology of bacterial co-infections in patients with COVID-19. Clin Microbiol Infect. 2020;26(12):1602–3. https://doi.org/10.1016/j.cmi.2020.09.002
Muñoz P, Valerio M, Vena A, et al. Antifungal stewardship in daily practice and health economic implications. Mycoses. 2015; 58 Suppl 2:14–25. https://doi.org/10.1111/myc.12329
Pappas PG, Kauffman CA, Andes D, et al. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35. https://doi.org/10.1086/596757
Santolaya ME, Alvarez AM, Acuña M, et al. Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial. J Antimicrob Chemother. 2018; 73(10):2860–6. https://doi.org/10.1093/jac/dky244
Bailly S, Bouadma L, Azoulay E, et al. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients. Am J Respir Crit Care Med. 2015;191(10):1139–46. https://doi.org/10.1164/rccm.201409-1701OC
Bassetti M, Righi E, Ansaldi F, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med. 2014;40(6):839–45. https://doi.org/10.1007/s00134-014-3310-z
Berman J, Krysan DJ. Drug resistance and tolerance in fungi. Nat Rev Microbiol. 2020;18(6):319–31. https://doi.org/10.1038/s41579-019-0322-2
Canela HMS, Cardoso B, Vitali LH, et al. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil. Mycoses. 2018;61(1):11–21. https://doi.org/10.1111/myc.12695
Colombo AL, Garnica M, Aranha Camargo LF, et al. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol. 2013;51(1):38–44. https://doi.org/10.3109/13693786.2012.698024
Doi AM, Pignatari AC, Edmond MB, et al. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program. PLoS One. 2016;11(1):e0146909. https://doi.org/10.1371/journal.pone.0146909
Motta FA, Dalla-Costa LM, Muro MD, et al. Risk factors for candidemia mortality in hospitalized children. J Pediatr (Rio J). 2017;93(2):165–71. https://doi.org/10.1016/j.jped.2016.05.007
Medeiros MAP, Melo APV, Bento AO, et al. Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study. PLoS One. 2019;14(8):e0221033. https://doi.org/10.1371/journal.pone.0221033
Souza LKH, Costa CR, Fernandes OF, et al. Clinical and microbiological features of cryptococcal meningitis. Rev Soc Bras Med Trop. 2013;46(3):343–7. https://doi.org/10.1590/0037-8682-0061-2012
Mezzari A, Wliebbelling AMP, Freitas GSO, et al. Cryptococcosis in a public hospital in Porto Alegre: epidemiological data. 2013. https://lume.ufrgs.br/handle/10183/196745. Accessed on February 2nd, 2024.
Mora DJ, Colombo ERC, Ferreira-Paim K, et al. Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil. Mycopathology. 2012;173(5–6):321–7. https://doi.org/10.1007/s11046-011-9504-9
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV. Organización Panamericana de la Salud 2020; https://iris.paho.org/handle/10665.2/52304. Accessed on February 2nd, 2024.
Sousa-Neto AL, Brito Röder DVD, Pedroso RS. Invasive fungal infections in people living with HIV/AIDS. J Biosc Med. 2020;08(09):15–26. https://doi.org/10.4236/jbm.2020.89002
Almeida MA, Almeida-Silva F, Guimarães AJ, et al. The occurrence of histoplasmosis in Brazil: A systematic review. Int J Infect Dis. 2019;86:147–56. https://doi.org/10.1016/j.ijid.2019.07.009
##submission.downloads##
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Reginaldo dos Santos Pedroso
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.
